DIVI'S LABORATORIES LTD. - 532488 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
As per attachment.08-04-2024
08-04-2024
DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Clippings - Intimation of notice given to shareholders in respect of transfer of equity shares to IEPF account08-04-2024
DIVI'S LABORATORIES LTD. - 532488 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Submission of Scrutinizer''s Report on e-voting on resolutions stated in Postal Ballot Notice dated February 10, 2024.05-04-2024
DIVI'S LABORATORIES LTD. - 532488 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Submisssion of Voting results on the resolutions proposed vide Postal Ballot Notice dated February 10, 2024 and Scrutinizer''s Report thereon.05-04-2024
DIVI'S LABORATORIES LTD. - 532488 - Closure of Trading Window
Intimation of closure of Trading Window from April 01, 2024 for declaration of audited financial results for the fourth quarter and year ending March 31, 2024.30-03-2024
DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement relating to Postal Ballot Notice05-03-2024
DIVI'S LABORATORIES LTD. - 532488 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Submission of Postal Ballot Notice dated February 10, 2024.04-03-2024
DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
We herewith enclose the Transcript of earnings conference call held on February 10, 2024.16-02-2024
DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copies of Newspaper publication12-02-2024
Q3FY24 Quarterly & 9MFY24 Result Announced for Divi's Laboratories Ltd.
Pharmaceuticals company Divi's Laboratories announced Q3FY24 & 9MFY24 results: Consolidated Q3FY24: Total Income: Rs 1,950 crore, compared to Rs 1,821 crore in the corresponding quarter of the previous year. Material Consumption: Approximately 39% of sales revenue. Profit Before Tax (PBT): Rs 489 crore, compared to Rs 435 crore in the corresponding quarter of the previous year. Profit After Tax (PAT): Rs 358 crore, compared to Rs 306 crore in the corresponding quarter of the previous year. Standalone Q3FY24: Total Income: Recorded at Rs 1,902 crore in Q3FY24 compared to Rs 1,807 crore in Q3FY23. Profit Before Tax (PBT): Stood at Rs 490 crore in Q3FY24, up from Rs 439 crore in Q3FY23. Profit After Tax (PAT): Amounted to Rs 358 crore in Q3FY24, higher than the Rs 310 crore in Q3FY23. Forex Gain: Registered at Rs 17 crore in Q3FY24, decreased from Rs 49 crore in Q3FY23. Consolidated 9MFY24: Total Income: Rs 5,804 crore, compared to Rs 6,099 crore in the corresponding previous period. Profit After Tax (PAT): Rs 1,062 crore, compared to Rs 1,502 crore in the corresponding previous period. Forex Gain: Rs 32 crore, compared to Rs 134 crore in the previous 9-month period. Standalone 9MFY24: Total Income: For 9MFY24, it amounted to Rs 5,665 crore, down from Rs 6,003 crore in 9MFY23. Profit Before Tax (PBT): For 9MFY24, it was Rs 1,432 crore, a decrease from Rs 1,886 crore in 9MFY23. Profit After Tax (PAT): For 9MFY24, it reached Rs 1,045 crore, down from Rs 1,489 crore in 9MFY23. Forex Gain: For 9MFY24, it stood at Rs 29 crore, a decline from Rs 137 crore in 9MFY23. Result PDF12-02-2024